Suspended

Pulmonary Nodule Localization Under Thoracoscopic Surgery- a Machine Learning Based Retrospective Analysis and Prospective Validation

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Lung Diseases+5

+ Lung Neoplasms

+ Neoplasms

Over 20 Years
+6 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: January 2021
See protocol details

Summary

Principal SponsorE-DA Hospital
Study ContactMing-Wei Kao, M.D., M.S.
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: January 23, 2021

Actual date on which the first participant was enrolled.

Excision of targeted lung nodules during thoracoscopy sometimes needs placing a mark before surgery. The procedure of mark placement (localization) could probably cause damages to the patients. However, the criteria for patient selection is still not clear. Through respective analysis, the investigators have set up a prediction model and wish to validate this model prospectively.

Official TitlePulmonary Nodule Localization Under Thoracoscopic Surgery- a Machine Learning Based Retrospective Analysis and Prospective Validation
NCT04690790
Principal SponsorE-DA Hospital
Study ContactMing-Wei Kao, M.D., M.S.
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

50 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 20 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Lung DiseasesLung NeoplasmsNeoplasmsNeoplasms by SiteRespiratory Tract DiseasesRespiratory Tract NeoplasmsThoracic NeoplasmsMultiple Pulmonary Nodules

Criteria

3 inclusion criteria required to participate
Age ≧ 20 years

Lung nodule size ≦2cm on the pre-operative computed tomography (CT)

Nodulectomy is performed under thoracoscopy

3 exclusion criteria prevent from participating
Lung nodule size > 2cm on CT or in the final pathology report

Age < 20 years

Open surgery for nodulectomy

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

E-DA Hospital

Kaohsiung City, TaiwanOpen E-DA Hospital in Google Maps
SuspendedOne Study Center